September 30, 2018 has changed from December 31, 2017 as follows; The Statements of Financial Position Consolidated Financial Statement Sept 30, 2018 Dec 31, 2017 YoY Current Assets 2,192.99 700.84 1,492.15
, 2003 (collectively, the “Notifications on Connected Transactions”). The transaction represents the transaction value of 2.96 percent of the net tangible assets of the Company (the net tangible assets as
; Assets (Mill. Baht) Total Liabilities & Shareholders' Equity (Mill. Baht) Total Assets was Baht 3,121.03 million, decreased Baht 911.63 million or 22.61%, mostly from a decrease in current assets of Baht
a subsid mendments the entioned transa enerate benef ll help to dive from televisi to increase re speculated th of the Comp ent the televisi n of assets of oard TorChor Disposal of As Directors’ o
Company has recorded the provisions amount of Baht 16.48 million to adjust out of the accounts in full 4.3.3 Impairment loss of non-current assets for sale amount Baht 90.73 million , the Company has
, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th Financial Position As of 31st March 2020 As of 31st December 2019 Change MB MB MB % Total Assets 549.35 525.87 23.48 4.47 Total Liabilities
) , Leases, which defined principles for the recognition, measurement, presentation, and disclosure of leases that the company commenced from January 1, 2020, onward. As a result, the use of assets and
, because RH’s and AVA’s power plants had been booked in the subsidiaries’ operational assets. As a result, the Company recognized the financial costs of each project in the income statement. In the second
65.16 13.80 Property, plant and equipment 933.67 919.08 14.59 1.59 Other assets 87.22 69.00 18.22 26.41 Total assets 1,750.03 1,775.85 (25.82) -1.45 Accounts payable 108.90 149.37 (40.47) -27.09 Long-term
. Explanation and analysis of financial status as at 30 September 2019 The group’s assets increased by Baht 31 million, mainly due to the following reasons: • Inventories increased by Baht 115 million. This was